Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnoCare OptoelectronicsTPE:6861 +4.04%65 Return-on-Tangible-Asset is 12.90% as of Mar. 2026, which is 95% above its 10-year median of 6.63. GuruFocus rates TPE:6861 with a GF Score™ of 65/100 and a GF Value™ of NT$94.34 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, InnoCare Optoelectronics ranks better than 75.91% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. InnoCare Optoelectronics's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$352 Mil. InnoCare Optoelectronics's average total tangible assets for the quarter that ended in Mar. 2026 was NT$2,730 Mil. Therefore, InnoCare Optoelectronics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 12.90%.
The historical rank and industry rank for InnoCare Optoelectronics's Return-on-Tangible-Asset or its related term are showing as below:
TPE:6861'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 4.75 Med: 6.63 Max: 10.74
Current: 8.03
During the past 8 years, InnoCare Optoelectronics's highest Return-on-Tangible-Asset was 10.74%. The lowest was 4.75%. And the median was 6.63%.
TPE:6861's Return-on-Tangible-Asset is ranked better than 75.91% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs TPE:6861: 8.03
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
InnoCare Optoelectronics Return-on-Tangible-Asset Related Terms
InnoCare Optoelectronics Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for InnoCare Optoelectronics's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6861 vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, InnoCare Optoelectronics's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 12.90% mean?
InnoCare Optoelectronics (TPE:6861) has a Return-on-Tangible-Asset of 12.90% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on InnoCare Optoelectronics and its competitors. This is 95% above median its historical median of 6.63. Over the past decade, InnoCare Optoelectronics' Return-on-Tangible-Asset has ranged from 4.75 to 10.74. According to the industry distribution chart, InnoCare Optoelectronics ranks #206 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is InnoCare Optoelectronics' Return-on-Tangible-Asset too high?
InnoCare Optoelectronics' current Return-on-Tangible-Asset of 12.90% is 95% above median its 10-year median of 6.63. Over the past 10 years, this metric has ranged from a low of 4.75 to a high of 10.74. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.56. InnoCare Optoelectronics' value of 12.90% is 2203.6% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #206 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, InnoCare Optoelectronics has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #206 out of 855 companies for Return-on-Tangible-Asset. This places InnoCare Optoelectronics in the top 24% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.56. InnoCare Optoelectronics' value of 12.90% is 2203.6% above this benchmark. Historically, InnoCare Optoelectronics' own Return-on-Tangible-Asset has ranged from 4.75 to 10.74 over the past decade. While the company's 10-year median is 6.63 vs. the industry median of 0.56, InnoCare Optoelectronics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.56, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current Return-on-Tangible-Asset of 12.90% is 2203.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on InnoCare Optoelectronics and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current Return-on-Tangible-Asset is 12.90%, which is 95% above median its own 10-year median of 6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$94.34, compared to a current price of NT$206.00 — trading 118.4% above its estimated fair value. The current Return-on-Tangible-Asset is 12.90%, which is 95% above median its 10-year median of 6.63 and 2203.6% above the Medical Devices & Instruments industry median of 0.56. InnoCare Optoelectronics' overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current Return-on-Tangible-Asset is 12.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$206.00 is trading 118.4% above its estimated GF Value™ of NT$94.34.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
Return-on-Tangible-Asset: 12.90% (95% above median its 10-year median of 6.63)
GF Value™: NT$94.34 vs. price of NT$206.00 (118.4% above fair value)
Industry Position: 2203.6% above the Medical Devices & Instruments median (#206 of 855)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
65GF Score
Get the complete analysis for TPE:6861
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
